|
Clinical study of AdV-tk radiogene therapy for malignant glioma
|
5R44CA107745-05
|
$510,001
|
|
Aguilar-Cordova, Estuardo
|
ADVANTAGENE, INC
|
|
Regulation of Fibronectin Matrix Assembly by uPAR
|
5R01CA058626-16
|
$281,080
|
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
Persistent HPV in Women at Risk for Cervix Cancer
|
5U01CA078527-12
|
$590,661
|
|
BURK, ROBERT
|
ALBERT EINSTEIN COL OF MED YESHIVA UNIV
|
|
miRNA Profiling in Fixed Cancer Samples
|
5R44CA118785-03
|
$622,242
|
|
BROWN, DAVID
|
AMBION DIAGNOSTICS, INC.
|
|
Molecular Biology in Clinical Oncology Workshop
|
5R25CA057732-18
|
$303,047
|
|
Kaelin, William
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Storytelling to Promote Colorectal Screening in Primary Care Clinics
|
7R01CA116467-04
|
$409,128
|
|
LARKEY, LINDA
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Engineering alpha fetoprotein and glypican-3 to develop hepatoma (HCC) vaccines
|
5R01CA168912-04
|
$320,588
|
$320,588
|
HE, YUKAI
|
AUGUSTA UNIVERSITY
|
|
TREM-1 and Its Implications to Cancer
|
5R01CA172230-04
|
$315,400
|
$315,400
|
HORUZSKO, ANATOLIJ
|
AUGUSTA UNIVERSITY
|
|
Role of heat shock transcription factor HSF1 in tumoroginesis
|
5R01CA062130-22
|
$556,510
|
$556,510
|
MIVECHI, NAHID
|
AUGUSTA UNIVERSITY
|
|
Development of cell-free DNA assays for HCC screening and liquid biopsy
|
5R01CA202769-02
|
$472,981
|
$472,981
|
SU, YING-HSIU
|
BARUCH S. BLUMBERG INSTITUTE
|
|
Roll Your Own (RYO) Cigarettes: Prevalence, Smoking Behavior and Toxin Exposure
|
1R01CA138973-01
|
$407,794
|
|
Pickworth, Wallace
|
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-20
|
$521,201
|
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
The Epidemiologic Effects of HAART on HIV-related Anal Cancer and Anal Dysplasia
|
5K23CA124318-04
|
$137,700
|
|
Chiao, Elizabeth
|
BAYLOR COLLEGE OF MEDICINE
|
|
A New Lab Based Algorithm for HCC Surveillance in Patients with Cirrhosis
|
5R01CA190776-03
|
$636,729
|
$636,729
|
EL-SERAG, HASHEM
|
BAYLOR COLLEGE OF MEDICINE
|
|
Translational Breast Cancer Research Training Program
|
5T32CA090221-07
|
$263,406
|
|
FUQUA, SUZANNE
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genetic analysis of mouse chromosome 11
|
5R01CA115503-04
|
$475,508
|
|
Justice, Monica
|
BAYLOR COLLEGE OF MEDICINE
|
|
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA
|
5R01CA086832-07
|
$279,192
|
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pilot and Feasibility Evaluation of a Walking School Bus Program Intervention for
|
5R21CA133418-02
|
|
|
Mendoza, Jason
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S1
|
$118,333
|
$3,550
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S2
|
$118,875
|
$3,566
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S3
|
$122,250
|
$3,668
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-11S4
|
$250,002
|
$7,500
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-11
|
$3,253,119
|
$97,594
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Neurobehavioral Late-Effects in Pediatric Brain Tumors
|
7R01CA112182-05
|
$506,986
|
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
De facto Target of Histone Deacetylase Inhibitors
|
1R21CA215591-01
|
$172,369
|
$172,369
|
SUN, ZHENG
|
BAYLOR COLLEGE OF MEDICINE
|
|
MiRNAs in hepatocellular carcinoma development and treatment
|
2R01CA139158-06A1
|
$410,875
|
$410,875
|
HUANG, WENDONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S1
|
$73,297
|
$1,466
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
3P30CA033572-34S2
|
$124,999
|
$2,500
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
5P30CA033572-34
|
$2,446,682
|
$48,934
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-02
|
$474,276
|
$161,254
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-04
|
|
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
AKT pathway as a therapeutic tumor vessel target
|
5R01CA131064-02
|
$402,342
|
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Harvard/Michigan Prostate Cancer Biomarker Clinical Ctr
|
5U01CA113913-05
|
$843,497
|
|
SANDA, MARTIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of NFAT and NFAT-Induced Genes in Carcinoma
|
2R01CA096710-06A2
|
$304,354
|
|
TOKER, ALEX
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
INHIBITION OF NUCLEAR TRANSPORT BY TUMOR SUPPRESSOR CC3
|
5R01CA114430-04
|
$232,676
|
|
SHTIVELMAN, EMMA
|
BIONOVO, INC.
|
|
Efficacy of Electrical Stimulation for Dysphagia in Head & Neck Cancer Patients
|
5R01CA120950-03
|
$541,584
|
|
LANGMORE, SUSAN
|
BOSTON MEDICAL CENTER
|
|
Cancer Control in Older Adults
|
5K05CA092395-09
|
$148,568
|
|
SILLIMAN, REBECCA
|
BOSTON MEDICAL CENTER
|
|
Regulation of apoptosis by PI 3-kinase/Akt signaling
|
5R01CA018689-33
|
$484,567
|
|
COOPER, GEOFFREY
|
BOSTON UNIVERSITY
|
|
Illuminating Dynamic Receptor Clustering in the Epidermal Growth Factor Receptor
|
1R01CA138509-01
|
$306,063
|
|
Reinhard, Bjoern
|
BOSTON UNIVERSITY
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
$104,424
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
$557,256
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Elucidating the role of the mTOR pathway in NF1-related tumorigenesis
|
5R01CA129814-03
|
$321,811
|
|
CICHOWSKI, KAREN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
MUC-1 related cancer immunity: determinants and predictive significance
|
5R01CA123170-04
|
$274,214
|
|
CRAMER, DANIEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Selenoproteins as targets for cancer prevention
|
5R01CA080946-17
|
$316,004
|
$316,004
|
GLADYSHEV, VADIM
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITamin D and omegA-3 triaL (VITAL)
|
1U01CA138962-01
|
$2,694,337
|
|
MANSON, JOANN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Integrative genomic framework for dissecting regulatory mechanisms underlying hepatocellular carcinoma
|
1R21CA209940-01A1
|
$227,331
|
$227,331
|
POCHET, NATHALIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Enabling Technologies for MRI-Guided Prostate Interventions
|
5R01CA111288-04
|
$750,573
|
|
TEMPANY, CLARE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research
|
6R01CA121941-04
|
$536,299
|
|
MESIROV, JILL
|
BROAD INSTITUTE, INC.
|
|
Improving The Quality Of Advanced Cancer Care With Disease Management
|
5R01NR010787-03
|
$170,863
|
|
DALY, BARBARA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Role of Lipocalin 24p3 in Apoptosis and Leukemia
|
5K01CA113838-05
|
$154,213
|
|
DEVIREDDY, LAXMINARAYANA
|
CASE WESTERN RESERVE UNIVERSITY
|
Total relevant funding to Liver Cancer for this search: $76,724,142
|